Peripheral and central neurochemical effects of the selective serotonin reuptake inhibitors (SSRIs) in humans and nonhuman primates: Assessing bioeffect and mechanisms of action

International Journal of Developmental Neuroscience

Volumn 22, Issue 5-6, 2004, Pages 397-404

  Anderson, George M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cerebrospinal fluid; Cisternal; Gestational; Infants; Newborn; Platelet; Rhesus monkey

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; CITALOPRAM; FLUVOXAMINE; SEROTONIN; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

AKATHISIA; AUTISM; BEHAVIOR; BEHAVIOR DISORDER; BREAST MILK; CEREBROSPINAL FLUID; CLINICAL TRIAL; DEVELOPMENTAL DISORDER; DRUG EFFECT; DRUG MECHANISM; GENETIC CODE; HERITABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IRRITABILITY; MANIA; NEUROCHEMISTRY; NONHUMAN; ONTOGENY; PERINATAL PERIOD; PRENATAL EXPOSURE; PRIMATE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PUERPERAL DEPRESSION; RESTLESSNESS; REVIEW; RHESUS MONKEY; SEROTONIN BLOOD LEVEL; SEROTONIN UPTAKE; SEX DIFFERENCE; SLEEP DISORDER; SUICIDAL BEHAVIOR; THROMBOCYTE; THROMBOCYTOPENIA; TREMOR;

MACACA MULATTA; PRIMATES;

EID: 4544316223     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2004.06.006     Document Type: Article

References (81)

1. A. Abbott British panel bans use of antidepressants to treat children Nature 423 2003 792
2. G.M. Anderson Genetics of childhood disorders: XLV. Autism, Part 4: Serotonin in autism J. Am. Acad. Child Adolesc. Psychiatr. 41 2002 1513 1516
3. Anderson, G.M., Barr, C., Lindell, S., Durhamm A., Shifrovich, I., Higley, J.D. (2003). Time course of sertraline's effects on serotonin neurochemistry in the rhesus monkey, Soc. Neurosci. Abstr., Abstract #371.5.
4. G.M. Anderson, A.J. Bennett, K.P. Weld, J.G. Pushkas, D.M. Ocame, and Higley JD Serotonin in cisternal cerebrospinal fluid of the rhesus monkey: basal levels and sertraline administration Psychopharmcology 161 2002 95 99
5. Anderson, G.M., Czarkowski, K., Ravski, N., Epperson, C.N., 2004. Platelet serotonin in newborns and infants: ontogeny, heritability and effect of in utero exposure to selective serotonin reuptake inhibitors (SSRIs). Pediatr. Res., in press (Epub 7 July 2004).
6. G.M. Anderson, I.N. Mefford, T.J. Tolliver, M.A. Riddle, D.M. Ocame, J.F. Leckman, and D.J. Cohen Serotonin in human lumbar cerebrospinal fluid: a reassessment Life Sci. 46 1990 247 255
7. G.M. Anderson, K.L. Teff, and S.N. Young Serotonin in cisternal cerebrospinal fluid of the rat: measurement and use as an index of functionally active serotonin Life Sci. 40 1987 2253 2260
8. G.M. Anderson, R.H. Segman, and R.A. King Serotonin and suicidality: the impact of fluoxetine administration. II: Acute neurobiological effects Israel J. Psychiatr. Relat. Sci. 32 1995 44 50
9. G.M. Anderson, J.M. Stevenson, and D.J. Cohen Steady-state model for plasma free and platelet serotonin in man Life Sci. 41 1987 1777 1785
10. M. Asberg Monoamine neurotransmitters in human aggressiveness and violence: a selective review Crim. Behav. Ment. Health 4 1994 303 327
11. A. Bal-Klara, and M.M. Bird The effects of various antidepressant drugs on the fine-structure of neurons of the cingulate cortex in culture Neuroscience 37 1990 685 692
12. S. Benmansour, M. Ceccchi, D.A. Morilak, G.A. Gerhardt, M. Javors, G.G. Gould, and A. Frazer Effects of chronic antidepressant treatments on serotonin transporter function, density and mRNA level J. Neurosci. 19 1999 10494 10501
13. A.J. Bennett, K.P. Lesch, A. Heils, J.C. Long, J.G. Lorenz, S.E. Shoaf, M. Champoux, S.J. Suomi, M.V. Linnoila, and J.D. Higley Early experience and serotonin transporter gene variation interact to influence primate CNS function Mol. Psychiatr. 7 2002 118 122
14. P. Blier, and C. De Montigny Current advances and trends in the treatment of depression Trends Pharmacol. Sci. 15 1994 220 226
15. C. Bolden-Watson, and E. Richelson Blockade by newly-developed antidepressants of biogenic amine uptake into brain synaptosomes Life Sci. 52 1993 1023 1029
16. G.L. Brown, and M.I. Linnoila CSF serotonin metabolite (5-HIAA) studies in depression, impulsivity and violence J. Clin. Psychiatr. 51 Supp 4 1990 31 41
17. M.A. Bunin, and R.M. Wightman Paracrine neurotransmission in the CNS: involvement of 5-HT Trends Neurosci. 22 1999 377 382
18. V.K. Burt, R. Suri, L. Altshuler, Z. Stowe, V.C. Hendrick, and E. Muntean The use of psychotropic medications during breast-feeding Am. J. Psychiatr. 58 2001 1001 1009
19. L.J. Buss, J. Lund, E. Bechgaard, and I. Sondergaard Inhibition of 5-HT uptake into platelet in mice treated chronically with chorimipramine and femoxetine Psychopharmacology 64 1970 149 153
20. G.A. Buznikov, H.W. Lambert, and J.M. Lauder Serotonin and serotonin-like substances as regulators of early embryogenesis and morphogenesis Cell Tissue Res. 305 2001 177 186
21. A. Caspi, K. Sugden, T.E. Moffitt, A. Taylor, I.W. Craig, H. Harrington, J. McClay, J. Mill, J. Martin, A. Braithwaite, and R. Poulton Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene Science 301 2003 386 389
22. C.N. Epperson, G.M. Anderson, and C.J. McDougle Sertraline and breastfeeding N. Engl. J. Med. 336 1997 1189 1190
23. C.N. Epperson, K.A. Czarkowski, D. Ward-O'Brien, E. Weiss, R. Gueorguieva, P. Jatlow, and G.M. Anderson Maternal sertraline treatment and serotonin transport in breastfeeding mother-infant pairs Am. J. Psychiatr. 158 2001 1631 1637
24. C.N. Epperson, P.I. Jatlow, K. Czarkowski, and G.M. Anderson Platelet serotonin in breastfeeding infants of mothers treated with fluoxetine Pediatrics 112 2003 e425 e429
25. L.A. Fairbanks, M.B. Fontenot, J.E. Phillips-Conroy, C.J. Jolly, J.R. Kaplan, and J.J. Mann CSF monoamines, age and impulsivity in wild grivet monkeys (Cercopithecus aethiops aethiops) Brain Behav. Evol. 53 1999 305 312
26. K.A. Fecteau, and H. Eiler Placental detachment: unexpected concentrations of 5-hydroxytryptamine in fetal blood and its mitogenic effects on placental cells in bovine Placenta 22 2000 101 110
27. F. Fernadez, S. Sarre, J. Launay, S. Aguerre, V. Guyonnet-Duperat, M. Moisan, G. Ebinger, Y. Michotte, P. Mormede, and F. Chaouloff Rat strain differences in peripheral and central serotonin transporter protein expression and function Eur. J. Neurosci. 17 2003 494 506
28. R. Fuller, and D. Wong Serotonin uptake and serotonin uptake inhibition Ann. N.Y. Acad. Sci. 600 1990 68 80
29. M.D. Gershon The Second Brain 1998 Harper-Collins New York
30. M.A. Grimes, J.L. Cameron, and J.D. Fernstrom Cerebrospinal fluid concentrations of trytophan and 5-hydroxyindolacetic acid in Macaca mulatta: diurnal variations and response to chronic changes in dietary protein intake Neurochem. Res. 25 2000 413 422
31. E. Gur, B. Lerer, and M.E. Newman Chronic clomipramine and triiodothyronine increase serotonin levels in rat frontal cortex in vivo: relationship to serotonin autoreceptor activity J. Pharmacol. Exp. Ther. 288 1999 81 87
32. A.R. Hariri, V.S. Mattay, A. Tessitore, B. Kolachana, F. Fera, D. Goldman, M.F. Egan, and D.R. Weinberger Serotonin transporter genetic variation and the response of the human amygdala Science 297 2002 400 403
33. J.D. Higley, and M. Linnoila Low central nervous system serotonergic activity is traitlike and correlates with impulsive behavior. A nonhuman primate model investigating genetic and environmental influences on neurotransmission. Ann. N.Y. Acad. Sci. 836 1997 39 56
34. W.Q. Huang, C.L. Zhang, X.Y. Di, and R.Q. Zhang Studies on the localization of 5-hydroxytryptamine and its receptors in human placenta Placenta 19 1998 655 666
35. J. Hyttel Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs) Int. Clin. Psychopharmacol. 9 Suppl. 1 1994 19 26
36. R. Invernizzi, M. Bramante, and Samanin R Role of 5-HT(1A) receptors in the effects of acute and chronic fluoxetine on extracellular serotonin in the frontal cortex Pharmacol. Biochem. Behav. 54 1996 143 147
37. F. Karege, J. Widmer, P. Bovier, and J. Gaillard Platelet serotonin and plasma tryptophan in depressed patients: effect of drug treatment and clinical outcome Neuropsychopharmacol. 10 1994 207 214
38. F. Kilic, D.L. Murphy, and G. Rudnick A human serotonin transporter mutation causes constitutive activation of transport activity Mol. Pharmacology. 64 2003 440 446
39. R.A. King, G.M. Anderson, A.M. Rasmusson, and M.A. Riddle Fluoxetine mechanisms of action (in reply) J. Am. Acad. Child Adolesc. Psychiatr. 30 1991 849 850
40. R.A. King, M.A. Riddle, P.B. Chappell, M.T. Hardin, G.M. Anderson, P.J. Lombroso, and L.D. Scahill Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment J. Am. Acad. Child Adolesc. Psychiatr. 30 1991 179 186
41. R.A. King, R.H. Segman, and G.M. Anderson Serotonin and suicidality: the impact of acute fluoxetine administration. I: Serotonin and suicide Israel J. Psychiatr. Relat. Sci. 31 1995 271 279
42. K. Laine, T. Heikkkinen, U. Ekblad, and P. Kero Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations Arch. Gen. Psychiatr. 60 2003 720 726
43. J.M. Lauder Neurotransmitters as growth regulatory signals: role of receptors and second messages Trends Neurosci. 16 1993 233 240
44. L. Lemberger, H. Rowe, R. Carmichael, R. Crabtree, J.S. Horng, F. Bymaster, and D. Wong Fluoxetine, a selective serotonin uptake inhibitor Clin. Pharmacol. Ther. 23 1978 421 429
45. K.P. Lesch Variation of serotonergic gene expression: neurodevelopment and the complexity of response to psychopharmacological drugs Eur. Neuropsychopharmacol. 11 2001 457 474
46. K.P. Lesch, B.L. Wolozin, D.L. Murphy, and P. Reiderer Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter J. Neurochem. 60 1993 2319 2322
47. O. Lingjaerde From clomipramine to mianserin: therapeutic relevance of interactions with serotonin uptake and storage, as studied in the blood platelet model Acta Psychiatr. Scand. 72 Suppl. 320 1985 10 19
48. I. Lucki The spectrum of behaviors influenced by serotonin Biol. Psychiatr. 44 1998 151 162
49. A. Martin, K. Koenig, G.M. Anderson, and L. Scahill Low-dose fluvoxamine treatment of children and adolescents with pervasive developmental disorders: a prospective, open-label study J. Autism Dev. Disorders 33 2003 77 85
50. M. Matsumoto, H. Togashi, M. Yoshioka, K. Morii, M. Hirokami, M. Tochihara, T. Ikeda, Y. Saito, and Saito H Significant correlation between cerebrospinal fluid and brain levels of norepinephrine, serotonin, and acetylcholine in anesthetized rats Life Sci. 48 1991 823 829
51. 11C]DASB PET imaging study Am. J. Psychiatr. 158 2001 1843 1849
52. J.R. Moiseiwitsch, and J.M. Lauder Serotonin regulates mouse cranial neural crest migration Proc. Natl. Acad. Sci. U.S.A. 92 1995 7182 7186
53. S. Montanez, W.A. Owens, G.G. Gould, D.L. Murphy, and L.C. Daws Exaggerated effect of fluvoxamine in heterozygote serotonin transporter knockout mice J. Neurochem. 86 2003 210 219
54. E. Mulder, G.M. Anderson, I. Kema, A. de Bildt, van Lang NDJ, J.A. den Boer, and R.B. Minderaa Platelet serotonin in pervasive developmental disorders and mental retardation J. Am. Acad. Child Adolesc. Psychiatr. 43 2004 491 499
55. E.J. Mulder, G.M. Anderson, I.P. Kema, and R.B. Minderaa Reactivity of whole blood serotonin Biol. Psychiatr. 51 2002 266 268
56. E. Mundo, M. Walker, T. Cate, F. Macciardi, and J.L. Kennedy The role of serotonin transporter protein gene in antidepressant-induced mania in bipolar disorder: preliminary findings Arch. Gen. Psychiatr. 58 2001 539 544
57. M. Narayan, G.M. Anderson, J. Cellar, R.T. Malison, L.H. Price, and J.C. Nelson Serotonin transporter blocking propeties of nefazodone assessed by measurement of platelet serotonin Biol. Psychiatr. 18 1998 67 71
58. D.J. Nutt Death and dependence: current controversies over the selective serotonin reuptake inhibitors J. Psychopharmacol. 17 2003 355 364
59. C. Ober, M. Abney, and M.S. McPeek The genetic dissection of complex traits in a founder population Am. J. Hum. Genet. 69 2001
60. T.F. Oberlander, R.E. Grunau, C. Fitzgerald, C. Ellwood, S. Misri, D. Rurak, and K.W. Riggs Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response Ped. Res. 51 2002 443 453
61. N. Ozaki, D. Goldman, W.H. Kaye, K. Plotnicov, B.D. Greenberg, J. Lappalainen, G. Rudnick, and D.L. Murphy Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype Mol. Psychiatr. 8 2003 933 936
62. J.E. Padbury, Y. Tseng, B. McGonnigal, K. Peando, M. Stephan, and G. Rudnick Placental biogenic amine transporters: cloning and expression Mol. Brain Res. 45 1997 163 168
63. K.W. Perry, and R.W. Fuller Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum Life Sci. 50 1992 1683 1690
64. G. Rudnick, and C.J. Humphreys Platelet serotonin transporter Methods Enzymol. 215 1992 213 224
65. Y. Sheline, M.E. Bardgett, and J.G. Csernansky Correlated reductions in cerebrospinal fluid 5-HIAA and MHPG concentrations after treatment with selective serotonin reuptake inhibitors J. Clin. Psychopharmacol. 17 1997 11 14
66. J. Sprouse, J. Braselton, L. Reynolds, T. Clarke, and H. Rollema Activation of postsynaptic 5-HT(1A) receptors by fluoxetine despite the loss of firing-dependent serotonergic input: electrophysiological and neurochemical studies Synapse 41 2001 49 57
67. M. Steiner, and T. Pearlstein Premenstrual dysphoria and the serotonin system: pathophysiology and treatment J. Clin. Psychiatr. 61 Suppl. 12 2000 17 21
68. T. Suhara, A. Takano, Y. Sudo, T. Ichimiya, M. Inoue, F. Yauno, Y. Ikoma, and Y. Okubo High levels of serotonin transporter occupancy with low-dose clomipramine in comparative occupancy study with fluvoxamine using positron emission tomography Arch. Gen. Psychiatr. 60 2003 386 391
69. R. Suri, Z.N. Stowe, V. Hendrick, A. Hostetter, M. Widawski, and L.L. Altshuler Estimates of nursing infant daily dose of fluoxetine through breast milk Biol. Psychiatr. 52 2002 446 451
70. M. Tatsumi, K. Groshan, R.D. Blakely, and E. Richelson Pharmaoclogical profile of antidepressants and related compounds on human monoamine transporters Eur. J. Pharmacol. 340 1997 249 258
71. P.A. Taylor, N. Garrick, L. Tamarkin, D.L. Murphy, and S.P. Markey Diurnal rhythms of N-acetylserotonin and serotonin in cerebrospinal fluid of monkeys Science 228 1985 900
72. M.H. Teicher, C. Glod, and J.O. Cole Emergence of intense suicidal preoccupation during fluoxetine treatment Am. J. Psychiatr. 147 1990 207 210
73. G.E. Torres, and M.G. Caron Center stage for the serotonin transporter: a gain-of-function polymorphism in persons with obsessive-compulsive disorder Mol. Pharmacol. 64 2003 196 198
74. C.V. Vorhees, K.D. Acuff-Smith, M.A. Schilling, J.E. Fisher, M.S. Moram, and J. Buelke-Sam A developmental neurotoxicity evaluation of the effects of prenatal exposure to fluoxetine in rats Fundam. Appl. Toxicol. 23 1994 194 205
75. F. Waechter Paroxetine must not be given to patients under 18 BMJ 326 2003 1282
76. L. Weiss, J. Veenstra-Vander Weele, M. Abney, H. Dytch, M.S. McPeek, S. Cheng, E. Cook, and C. Ober Genome-wide association mapping in a founder population identifies ITGB3 as a QTL for whole blood serotonin levels Am J. Hum. Genet. 73 Supp 5 2003 178 (abstract)
77. P.M. Whitaker-Azmitia Serotonin and brain development: role in human developmental diseases Brain Res. Bull. 56 2001 479 485
78. P.M. Whitaker-Azmitia, M. Druse, P. Walker, and J.M. Lauder Serotonin as a developmental signal Behav. Brain Res. 73 1996 19 29
79. K. Yonkers The association between premenstrual dysphoric disorder and other mood disorders J. Clin. Psychiatr. 58 Suppl. 15 1997 19 25
80. S.N. Young, F.R. Ervin, R.O. Pihl, and Finn P Biochemical aspects of tryptophan depletion in primates Psychopharmacology 98 1989 508 511
81. P.S. Zeskind, and L.E. Stephens Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn behavior Pediatrics 113 2004 368 375